康基醫療(09997.HK)建議以協議安排方式私有化及撤銷公司上市地位 8月13日復牌
格隆匯8月12日丨康基醫療(09997.HK)公吿,於2025年7月17日,要約人Knight Bidco Limited要求董事會向股東提呈該建議,內容有關建議根據公司法第86條以協議安排方式將公司私有化。於該建議完成後,公司將成為要約人的全資附屬公司,而股份於聯交所的上市地位將被撤銷。
註銷價格9.25港元指股份於最後交易日在聯交所所報的收市價每股8.42港元溢價約9.9%;董事會將適時經獨立董事委員會批准後,委任獨立財務顧問,以根據收購守則第2.1條就該建議向獨立董事委員會提供意見。公司於委任獨立財務顧問後將另行刊發公吿。
公司將於該計劃生效後在合理可行的情況下儘快根據上市規則第6.15(2)條向聯交所申請撤銷股份於聯交所的上市地位。
由於交易價格持續承壓且股份流動性有限,公司從股權市場籌集資金能力受到限制。鑑於上述情況,考慮到上市相關成本,公司維持上市地位裨益有限。同時,實施該建議將緩解公司短期財務表現壓力,促使公司更專注於需要額外資源配置戰略目標,以實現未來可持續增長。
公司已向聯交所申請股份自2025年8月13日上午九時起恢復買賣。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.